Dietary interventions in prostate cancer

Doll R, Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981, 66:1191–1308.

Aggarwal BB, Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006, 71:1397–1421.

Chan JM, Gann PH, Giovannucci EL: Role of diet in prostate cancer development and progression. J Clin Oncol 2005, 23:8152–8160.

Demark-Wahnefried W, Moyad MA: Dietary intervention in the management of prostate cancer. Current Opin Urol 2007, 17:168–174.

Fleshner N, Zlotta AR: Prostate cancer prevention: past, present, and future. Cancer 2007, 110:1889–1899.

Shukla S, Gupta S: Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 2005, 53:18–32.

Thompson IM, Tangen CM, Klein EA, Lippman SM: Phase III prostate cancer prevention trials: are the costs justified? J Clin Oncol 2005, 23:8161–8164.

Canby-Hagino, Thompson IM: Mechanism of disease: prostate cancer—a model for cancer chemoprevention in clinical practice. Nature Clin Pract Oncol 2005, 2:255–261.

Lamb DJ, Zhang L: Challenges in prostate cancer research: animal models for nutritional studies of chemoprevention and disease progression. J Nutr 2005, 135(12 S):3009S–3015S.

Department of Health and Human Services, US Department of Agriculture: Dietary guidelines for Americans, 2005. Accessible at http://www.health.gov/dietaryguidelines . Accessed on January 2007.

Pryor WA, Stahl W, Rock CL: Beta carotene: from biochemistry to clinical trials. Nutr Rev 2000, 58:39–53.

The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group: The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J M 1994, 330:1029–1035.

Omenn GS, Goodman GE, Thornquist MD, et al.: Risk factors for lung cancer and the intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 1996, 88:1550–1559.

Weinstein SJ, Wright ME, Lawson KA, et al.: Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007, 16:1253–1259.

Bairati I, Meyer F, Jobin E, et al.: Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 2006, 119:2221–2224.

Miller ER III, Pastor-Barriuso R, Dalal D, et al.: Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37–46.

Potter JD: Food and Cancer Prevention II: summary of the meeting. Cancer Letters 1997, 114:337–38.

Bjelakovic G, Nikolova D, Glund LL, et al.: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and metaanalysis. JAMA 2007, 297, 842-857.

Lawson KA, Wright ME, Subar A, et al.: Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 2007, 99:754–764.

Food and Nutrition Board/National Academy of Sciences/Institutes of Medicine. Dietary Reference Intakes. Accessible at http://www.iom.edu/Object.File/Master/21/372/0.pdf . Accessed on January 10, 2008.

Reid ME, Stratton MS, Lillico AJ, et al.: A report of highdose selenium supplementation: response and toxicities. J Trace Elements Med Biol 2004, 18:69–74.

Williams R, Ansford A: Acute selenium toxicity: Australia’s second fatality. Pathol 2007, 39:289–290.

Bemis DL, Capodice JL, Costello JE, et al.: The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer. Current Oncol Reports 2006, 8:228–236.

Schmid HP, Engeler DS, Pummer K, Schmitz-Drager BJ: Prevention of prostate cancer: more questions than data. Recent Results Cancer Res 2007, 174:101–107.

Ansari MS, Gupta NP: A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. Br J Urol Int 2003, 92:375–378.

Bunker CH, McDonald AC, Evans RW, et al.: A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutr Cancer 2007, 57:130–137.

Kucuk O, Sarkar FH, Sakr W, et al.: Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001, 10:861–868.

Hoenjet KM, Dagnelie PC, Delaere KP, et al.: Effect of a nutritional supplement containing vitamin E, selenium, vitamin C and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study. Euro Urol 2005, 47:433–439.

Kranse R, Dagnelie PC, van Kemende MC, et al.: Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled trial. Int J Cancer 2005, 113:835–840.

Schröder FH, Roobol MJ, Boevé ER, et al.: Randomized double blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Euro Urol 2005, 48:922–931.

Hamilton-Reeves JM, Rebello SA, Thomas W, et al.: Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen-beta expression or serum hormonal profiles in men at high risk of prostate cancer. J Nutr 2007, 137:1769–1775.

Kumar NB, Cantor A, Allen K, et al.: The specific role of isoflavones in reducing prostate cancer risk. Prostate 2004, 59:141–147.

Dalais FS, Meliala A, Wattanapenpaiboon N, et al.: Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urol 2004, 64:510–515.

Bylund A, Lundin E, Zhang JX, et al.: Randomised controlled short-term intervention pilot study on rye bread in prostate cancer. Euro J Cancer Prevent 2003, 12:407–415.

Ornish D, Weidner G, Fair WR, et al.: Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 2005, 174:1065–1070.

Lippman SM, Goodman PJ, Klein EA, et al.: Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005, 97:94–102.

Marshall JR, Sakr W, Wood D, et al.: Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 2006, 15:1479–1484.

Etminan M, FitzGerald JM, Gleave M, et al.: Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control 2005, 16:1125–1131.

MacInnes RJ, English DR: Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006, 17:989–1003.

Rodriguez C, Freedland SJ, Deka A, et al.: Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2007, 16:63–69.

Wright ME, Chang SC, Schatzkin A, et al.: Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007, 109:675–684.

Doyle C, Kushi LH, Byers T, et al.: Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2006, 56:323–353.

World Cancer Research Fund/American Institute for Cancer Research: Second Expert Report, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007.

Halabi S, Ou SS, Vogelzang NJ, Small E: Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer. Cancer 2007, 110:1478–1484.

Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al.: Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metabol Care 2007, 10:433–442.

Laviano A, Meguid MM, Inui A, et al.: Therapy insight: cancer anorexia-cachexia syndrome—when all you can eat is yourself. Nature Clin Pract Oncol 2005, 2:158–165.

Podgorski I, Linebaugh BE, Sloane BF: Cathepsin K in the bone microenvironment: link between obesity and prostate cancer? Biochem Soc Transactions 2007, 35:701–703.

DeMarzo AM, Platz EA, Sutcliffe S, et al.: Inflammation in prostate carcinogenesis. Nature Rev Cancer 2007, 7:256–269.

Freedland SJ, Platz EA: Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 2007, 29:88–97.

Demark-Wahnefried W, Aziz N, Rowland J, Pinto BM: Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005, 23:5814–5830.